MHT after endometrial mischief

Dr Jim Tsaltas

Menopause Hormonal Therapy (MHT) is regarded as the most effective treatment for menopausal symptoms. However, there are ongoing concerns regarding the use of hormones after treatment for conditions such as endometrial and other gynaecological malignancies and endometriosis. The understanding of how to implement these therapies amongst clinicians is poorly understood and as a consequence, menopausal symptoms are either overlooked or inadequately managed.  In this lecture we hope to look at some strategies to manage these issues in the most appropriate manner.


Biography:

Dr Jim Tsaltas is head of gynaecological endoscopy and endometriosis surgery at Monash Health and Monash University.

He is also senior IVF Specialist and a clinical director at Melbourne IVF.

His main areas of research are endometriosis and complex reproductive surgery. Also the impact of endometriosis non infertility and IVF outcomes. He has published widely and presented at many International Australian meetings.

Australasian Menopause Society

The Australasian Menopause Society (AMS) is the peak body representing doctors and other health care professionals who each have a special interest in women’s midlife health, the menopause and the promotion of healthy ageing.

 

The aim of the AMS is the advancement of knowledge about the menopause.  As well as holding an annual scientific congress in Australia and New Zealand, some AMS members are involved with the Asia-Pacific and International Menopause Societies, recognising that women living in Australia and New Zealand may have widely differing experiences of menopause.

 

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.

© 2018 - 2019 Conference Design Pty Ltd